Not shy of multi-billion-dollar acquisitions, Thermo Fisher says it expects to spend another $40-50 billion on “disciplined” M&A when the time is right. Since the formation of Thermo Fisher through the merger of Thermo Electron and Fisher Scientific in 2006, the company has made 44 acquisitions across all aspects of the life sciences services space, representing more than $69 billion. Some of the biggest include the $13.6 billion Life Technologies buy in 2013, the $7.2 billion acquisition of contract manufacturer Patheon…

CDMO uBriGene will expand into the US market through the acquisition of Mustang Bio’s manufacturing facility in Boston, Massachusetts. The deal, of which financial details have not been disclosed, sees cell and gene therapy (CGT) contract development and manufacturing organization (CDMO) uBriGene acquire a GMP manufacturing plant from Mustang Bio in Worcester, Massachusetts. uBriGene is headquartered in Vancouver, Canada and already has two manufacturing facilities in China. The 27,000 square-foot Worcester manufacturing site has clinical facilities for the production of…